Electromagnetic field investigation on different cancer cell lines

Cancer Cell International

Branislav Jeremic³  Aleksandar Peulic¹  Snezana Markovic⁴  Milena Curcic⁴  Danijela Cvetkovic⁴  Milos Radovic²  Tijana Djukic²  Nenad Filipovic² 

[1] Faculty of Engineering, University of Kragujevac, Sestre Janjica 6, Kragujevac, 34000, Serbia;BioIRC Bioengineering R&D Center, Kragujevac, Serbia;Institute of Pulmonary Diseases, Sremska Kamenica, Serbia;Laboratory for cell & molecular biology, Faculty of Science, University of Kragujevac, Kragujevac, Serbia

关键词: Colon cancer;    Breast cancer;    Computer simulation;    Electromagnetic fields;   

Others  :  1121667
DOI  :  10.1186/s12935-014-0084-x

 received in 2014-05-21, accepted in 2014-08-11,  发布年份 2014

【 摘 要 】

Background

There is a strong interest in the investigation of extremely low frequency Electromagnetic Fields (EMF) in the clinic. While evidence about anticancer effects exists, the mechanism explaining this effect is still unknown.

Methods

We investigated in vitro, and with computer simulation, the influence of a 50 Hz EMF on three cancer cell lines: breast cancer MDA-MB-231, and colon cancer SW-480 and HCT-116. After 24 h preincubation, cells were exposed to 50 Hz extremely low frequency (ELF) radiofrequency EMF using in vitro exposure systems for 24 and 72 h. A computer reaction-diffusion model with the net rate of cell proliferation and effect of EMF in time was developed. The fitting procedure for estimation of the computer model parameters was implemented.

Results

Experimental results clearly showed disintegration of cells treated with a 50 Hz EMF, compared to untreated control cells. A large percentage of treated cells resulted in increased early apoptosis after 24 h and 72 h, compared to the controls. Computer model have shown good comparison with experimental data.

Conclusion

Using EMF at specific frequencies may represent a new approach in controlling the growth of cancer cells, while computer modelling could be used to predict such effects and make optimisation for complex experimental design. Further studies are required before testing this approach in humans.

【 授权许可】

   
2014 Filipovic et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Polk C: Therapeutic applications of low-frequency sinusoidal and pulsed electric and magnetic fields. In The Biomedical Engineering Handbook. Edited by Bronzino JD. CRC Press, Boca Raton, FL; 1995:1404-1406.
• [2]Palti Y: Stimulation of internal organs by means of externally applied electrodes. J Appl Physiol 1966, 21:1619-1623.
• [3]Besset CA: The development and application of pulsed electromagnetic fields (PEMFs) for ununited fractures and arthrodeses. Clin Plast Surg 1985, 12:259-277.
• [4]Chou CK: Radiofrequency hyperthermia in cancer therapy. In The Biomedical Engineering Handbook. Edited by Bronzino JD. CRC Press, Boca Raton, FL; 1995:1424-1430.
• [5]Elson E: Biologic effects of radiofrequency and microwave fields in vivo and in vitro experimental results. In The Biomedical Engineering Handbook. Edited by Bronzino JD. CRC Press, Boca Raton, FL; 1995:1417-1423.
• [6]Zimmerman U, Vienken J, Piwat G: Rotation of cells in an alternating electric field: the occurrence of a resonance frequency. Z Naturforsch C 1981, 36:173-177.
• [7]Holzapfel C, Vienken J, Zimmermann U: Rotation of cells in an alternating electric field: theory and experimental proof. J Membr Biol 1982, 67:13-26.
• [8]Pawlowski P, Szutowicz I, Marszalek P, Fikus M: Bioelectrorheological model of the cell. 5. Electrodestruction of the cellular membrane in alternating electrical field. Biophys J 1993, 65:541-549.
• [9]Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzakhi A, Wasserman Y: Disruption of cancer cell replication by alternating electric fields. Cancer Res 2004, 64:3288-3295.
• [10]Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, Itzakhi A: Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci 2007, 104:10152-10157.
• [11]Zimmerman JW, Pennison MJ, Brezovich I, Yi N, Yang CT, Ramaker R: Cancer cell proliferation is inhibited by specific modulation frequencies. Br J Cancer 2012, 106:307-313.
• [12]Barbault A, Costa FP, Bottger B, Munden RF, Bomholt F, Kuster N: Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. J Exper Clin Cancer Res 2009, 28:51. BioMed Central Full Text
• [13]Zimmerman JW, Jimenez H, Pennison MJ, Brezovich I, Morgan D, Mudry A, Costa FP, Barbault A, Pasche B: Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies. Chin J Cancer 2013, 32:573-581.
• [14]Fang M, Zhang HQ, Xue SB: Role of Calcium in apoptosis of HL-60 cells induced by harring tonine. Science in China, Ser C 1998, 41:600-607.
• [15]Silva CP, Oliveira CR, Lima MCP: Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem Pharmacol 1996, 51:1331-1340.
• [16]Zhang X, Zhang H, Zheng C, LI C, Zhang X, Xiong W: Extremely Low Frequency (ELF) pulsed-gradient magnetic fields inhibit malignant tumour growth at different biological levels. Cell Biol Int 2002, 26:599-603.
• [17]Harris PA, Lamb J, Heaton B, Wheatley DN: Possible attenuation of the G2 DNA damage cell cycle checkpoint in HeLa cells by extremely low frequency (ELF) electromagnetic fields. Cancer Cell Int 2002, 2:3. BioMed Central Full Text
• [18]Cameron IL, Sun LZ, Short N, Hardman WE, Williams CD: Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis. Cancer Cell Int 2005, 5:23. doi:10.1186/1475-2867-5-23 BioMed Central Full Text
• [19]Costa FP, de Oliveira AC, Meirelles R, Machado MCC, Zanesco T, Surjan R, Chammas MC, de Souza RM, Morgan D, Cantor A, Zimmerman J, Brezovich I, Kuster N, Barbault A, Pasche B: Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields. Br J Cancer 2011, 105:640-648.
• [20]Gevertz JL, Gillies GT, Torquato S: Simulating tumor growth in confined heterogeneous environments. Phys Biol 2008, 5:036010.
• [21]Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983, 65:55-63.
• [22]Baskić D, Popović S, Ristić P, Arsenijević NN: Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol Int 2006, 30:924-932.
• [23]Yu Q, Liu Y, Wang C, Sun D, Yang X, Liu Y, Liu J: Chiral Ruthenium(II) polypyridyl complexes: stabilization of g-quadruplex DNA, inhibition of telomerase activity and cellular uptake. PLoS One 2012, 7(12):e50902. doi:10.1371/journal.pone.0050902
• [24]Swanson KR, Brigde C, Murray JD, Ellsworth AC Jr: Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 2003, 216:1-10.
• [25]Rockne R, Alvord EC Jr, Rockhill JK, Swanson KR: A mathematical model for brain tumor response to radiation therapy. J Math Biol 2009, 58:561-578.
• [26]Woodward DE, Cook J, Tracqui P, Cruywagen GC, Murray JD, Alvord EC Jr: A mathematical model of glioma growth: the effect of extent of surgical resection. Cell Prolif 1996, 29:269-288.
• [27]Tracqui P, Cruywagen GC, Woodward DE, Bartoo GT, Murray JD, Alvord EC Jr: A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth. Cell Prolif 1995, 28:17-31.
• [28]Filipovic N, Peulic A, Zdravkovic N, Grbovic-Markovic V, Jurisic-Skevin A: Transient finite element modeling of functional electrical stimulation. Gen Physiol Biophys 2011, 30:59-65.
• [29]Holland JH: Adaptation in Natural and Artificial Systems. University of Michigan Press, Ann Arbor; 1975.
• [30]Nelder J, Mead R: A simplex method for function minimization. Comput J 1965, 7:308-313.
• [31]Kirson ED, Schneiderman RS, Dbaly V, Tovarys F, Vymazal J, Itzhaki A: Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). BMC Med Phys 2009, 9:1-13. BioMed Central Full Text
• [32]Salzberg M, Kirson E, Palti Y, Rochlitz C: A pilot study with very low intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors. Onkologie 2008, 31:362-365.
• [33]Kirson ED, Giladi M, Gurvich Z, Itzhaki A, Mordechovich D, Schneiderman RS: Alternating electric fields (TTFields) inhibitmetastatic spread of solid tumors to the lungs. Clin Exp Metastasis 2009, 26:633-640.
• [34]Schneiderman RS, Shmueli E, Kirson ED, Palti Y: TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that overexpress ABC transporters. BMC Cancer 2010, 10:229. BioMed Central Full Text
• [35]Kaszuba-Zwoinska J, Wojcik K, Bereta M, Ziomber A, Pierzchalski P, Rokita E, Marcinkiewicz J, Zaraska W, Thor P: Pulsating electromagnetic field stimulation prevents cell death of puromycin treated u937 cell line. J Physiol Pharmacol 2010, 61(2):201-205.
• [36]Watson JM, Parrish EA, Rinehart CA: Selective potentiation of gynecologic cancer cell growth in vitro by electromagnetic fields. Gynecol Oncol 1998, 71:64-71.
• [37]Saliev T, Tachibana K, Bulanin D, Mikhalovsky S, Whitby RD: Bio-effects of non-ionizing electromagnetic fields in context of cancer therapy. Front Biosci (Elite Ed) 2014, 6:175-184.
• [38]Artacho-Cordón F, Salinas-Asensio Mdel M, Calvente I, Ríos-Arrabal S, León J, Román-Marinetto E, Olea N, Núñez MI: Could radiotherapy effectiveness be enhanced by electromagnetic field treatment? Int J Mol Sci 2013, 14:14974-14995.
• [39]Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, et al.: Novottf-100a versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 2012, 48:2192-2202.